← Back to Search

Behavioral Activation Teletherapy for Depression (BAT Trial)

N/A
Recruiting
Led By Chad Rethorst, PhD
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be18-64 years old
Able and willing to provide informed consent
Timeline
Screening 2 days
Treatment Varies
Follow Up 60 days
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at whether a ten-session behavior intervention delivered over teletherapy can help people with depression become more active and improve their symptoms.

Who is the study for?
This trial is for adults aged 18-64 with moderate-to-severe depression who are not very active physically (less than 90 minutes of activity a week) and want to be more active. They must have a smartphone, score ≥10 on the PHQ-9 depression scale, and give informed consent. People in current psychotherapy or at high risk for suicide can't join.
What is being tested?
The study tests a short program called Behavioral Activation Teletherapy over ten sessions aimed at increasing physical activity through remote therapy to help reduce symptoms of depression.
What are the potential side effects?
Since this intervention involves therapy rather than medication, typical medical side effects aren't expected. Participants may experience emotional discomfort discussing personal issues during sessions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 64 years old.
Select...
I have moderate to severe depression, scored 10 or higher on PHQ-9.
Select...
You are not physically active enough and do not engage in at least 90 minutes of moderate-to-vigorous physical activity per week.
Select...
You have shown that you want to exercise more.
Select...
You need to have a smartphone.

Timeline

Screening ~ 2 days
Treatment ~ Varies
Follow Up ~60 days
This trial's timeline: 2 days for screening, Varies for treatment, and 60 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Feasibility and acceptability - Recruitment
Feasibility and acceptability - Screening
Intervention Adherence
+3 more
Secondary study objectives
Depressive symptoms - 9-item Patient Health Questionnaire
Physical activity - Fitbit step counter active minutes
Physical activity - Fitbit step counter step count
+2 more
Other study objectives
Depressive symptoms - IDS-SR
Mediation of intervention through a number of pathways
Minimum number of therapy sessions needed to achieve depression remission

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Behavioral Activation TeletherapyExperimental Treatment1 Intervention
All eligible participants will be assigned to receive the behavioral activation teletherapy intervention.

Find a Location

Logistics

Other reimbursement is provided

Other forms of reimbursement are provided for this trial.

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
1,088 Previous Clinical Trials
1,059,655 Total Patients Enrolled
46 Trials studying Depression
19,336 Patients Enrolled for Depression
Chad Rethorst, PhDPrincipal InvestigatorUniversity of Texas Southwestern Medical Center
1 Previous Clinical Trials
38 Total Patients Enrolled
1 Trials studying Depression
38 Patients Enrolled for Depression
Joseph M Trombello, PhD, ABPPPrincipal InvestigatorUniversity of Texas Southwestern Medical Center
Madhukar Trivedi, MDPrincipal InvestigatorUniversity of Texas Southwestern Medical Center
14 Previous Clinical Trials
10,778 Total Patients Enrolled
8 Trials studying Depression
9,721 Patients Enrolled for Depression

Media Library

Behavioral Activation Teletherapy Clinical Trial Eligibility Overview. Trial Name: NCT04990401 — N/A
Depression Research Study Groups: Behavioral Activation Teletherapy
Depression Clinical Trial 2023: Behavioral Activation Teletherapy Highlights & Side Effects. Trial Name: NCT04990401 — N/A
Behavioral Activation Teletherapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT04990401 — N/A
Depression Patient Testimony for trial: Trial Name: NCT04990401 — N/A
~15 spots leftby Dec 2025